Search
Aurora Cannabis Inc
ACBAdd to Watchlist
3.680USD
-0.110-2.90%
Close 08-14 16:00（ET）Quotes delayed by 15 min
232.98MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Aurora Cannabis Inc is 7.20, ranking 107 out of 156 in the Pharmaceuticals industry. The average price target is 32.00, with a high of 32.00 and a low of 32.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
32.000
Target Price
+443.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Aurora Cannabis Inc
ACB
4
Biogen Inc
BIIB
37
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
32
Regeneron Pharmaceuticals Inc
REGN
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Aurora Cannabis Inc's expected revenue for the next quarter?
Aurora Cannabis Inc's expected revenue is 52.15M.
What is Aurora Cannabis Inc's price target?
Analysts forecast that Aurora Cannabis Inc's price target is USD 32.00, with the highest forecast at USD 32.00 and the lowest forecast at USD 32.00.
How have Aurora Cannabis IncACB's recent earnings per share performed?
The market expectation was USD -0.05, while Aurora Cannabis IncACB's earnings per share (EPS) for the previous quarter was USD -0.71. EPS for the next quarter is expected at USD -0.10.
What is the analyst rating for Aurora Cannabis Inc?
Based on the ratings of Aurora Cannabis Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.